Bernhard Günther Christian Roesky, PhD, CEO and managing director of Novaliq GmbH, explains how the company’s water-free ophthalmic therapies can bring new treatments to ophthalmology’s most vexing conditions including dry eye. And what valuable lessons has he learned as CEO of the start-up.